Investment Partners Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
1,408
+104
+8% +$106K 0.94% 27
2026
Q1
$1.2M Buy
1,304
+52
+4% +$52.7K 0.74% 36
2025
Q4
$1.35M Buy
1,252
+448
+56% +$428K 0.84% 32
2025
Q3
$613K Buy
804
+420
+109% +$313K 0.4% 71
2025
Q2
$299K Buy
384
+39
+11% +$30.3K 0.21% 123
2025
Q1
$285K Buy
+345
New +$287K 0.22% 117

Other funds holding LLY

Investment Partners Asset Management's LLY Position: Q2 2026 in Review

Investment Partners Asset Management increased its Eli Lilly (LLY) stake by 8% in Q2 2026, buying an estimated $106K and bringing the position to 1,408 shares worth $1.69M. The position accounts for 0.94% of the portfolio, ranked #27.

Investment Partners Asset Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Investment Partners Asset Management held 1,408 shares of Eli Lilly worth $1.69M as of Q2 2026.
  • Investment Partners Asset Management bought 104 Eli Lilly shares in Q2 2026, an estimated $106K.
  • Eli Lilly made up 0.94% of Investment Partners Asset Management's portfolio in Q2 2026, its #27 holding.
  • Investment Partners Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.